Human pluripotent stem cell differentiation into authentic striatal projection neurons.

Area of Science:

• Neuroscience
• Developmental Biology
• Stem Cell Biology

Background:

• Huntington's Disease (HD) involves the degeneration of medium spiny neurons (MSNs) in the striatum.
• Existing models for studying HD pathogenesis and drug discovery are limited.
• A reliable method to generate authentic human MSNs in vitro is needed.

Purpose of the Study:

• To present a robust protocol for differentiating human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into authentic human striatal projection medium spiny neurons (MSNs).
• To establish a platform for in vitro developmental neurobiology, drug screening, and regenerative medicine approaches for Huntington's Disease.

Main Methods:

• Neural induction via BMP/TGF-β inhibition followed by exposure to SHH and DKK-1 for ventral telencephalic specification.
• Monitoring differentiation via specific cell markers (FOXG1, GSX2, CTIP2, FOXP1, FOXP2) at defined time points.
• Characterization of mature neurons by MAP2, GABA, DARPP-32 co-expression and electrophysiological properties.

Main Results:

• The 80-day protocol yields authentic human striatal MSNs, validated by multiple cellular and electrophysiological features.
• Key progenitor cell markers (FOXG1+/GSX2+) appear at days 15-25, followed by specific neuronal markers (CTIP2-, FOXP1-, FOXP2-) at day 45.
• Mature neurons exhibit expected electrophysiological properties, with 20% co-expressing diagnostic markers DARPP-32 and CTIP2.

Conclusions:

• The developed protocol reliably generates authentic human striatal MSNs from multiple pluripotent cell lines.
• This method provides a valuable in vitro model for Huntington's Disease research, drug screening, and regenerative medicine.
• The protocol's replicability and authenticity make it a significant advancement for neurological disease modeling.